Offerings for Academia – Phoenix Page
Certara is proud to support academic institutions with access to industry-leading tools from the Phoenix portfolio.
Using SDTM Data to Produce Patient Narratives Blog Post
In this blog, we look at how medical writers can use SDTM data produced by BioStats teams to prepare high quality patient narratives.
How to Use Fix Tips for Better Clinical Data Issue Management Blog Post
Julie Ann Hood Principal Consultant 2025年4月15日 Clinical data issue management: the basics Prior to submission to any regulatory agency, standardized study data is evaluated using at least one validation tool to ensure...
PharmaSUG 2025 Blog Post
[event_date_range] – [acf field="event_location"] – Booth [acf field="event_booth"]
Using cost-effectiveness models for smarter drug development and healthcare decisions Blog Post
Noemi Hummel Mohsen Yaghoubi 2025年4月14日 Editor’s note: This is the second in a series of four articles on the crucial role health economic modeling plays in evaluating the...
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing Blog Post
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies RADNOR, PA —2025年4月14日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) は本日、Kor...
Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization Blog Post
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, PA — April 14, 2025 - Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) は、本日Chemaxon (ケムアクソン)社の買収完了を発表しました。...
FDAのmAbsに対する動物実験の段階的廃止に向けた準備と対策は万全ですか？ Blog Post
講演者Fran Brown, PhD Senior Vice President, Certara Drug Development Solutions Fran has over 25 years of experience with strategic and operational global drug development from early discovery to filing...
